Amplification of fibroblast growth factor receptor 2 (FGFR2) is also frequent in CIN GCs [4], and is of considerable interest due to clinical trials investigating FGFR inhibitors. The gene discussed is FGFR2; the disease is cervical squamous intraepithelial neoplasia.